COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants

Area of Science:

• * Infectious Diseases and Virology
• * Immunology and Pharmacology

Background:

• * The COVID-19 pandemic, caused by SARS-CoV-2, presents an ongoing global health challenge.
• * Viral mutations lead to variants and sublineages, impacting the effectiveness of existing treatments and vaccines.
• * Therapeutic strategies are crucial for managing disease severity and protecting high-risk populations.

Purpose of the Study:

• * To review current COVID-19 treatments, including antiviral and immune-based strategies.
• * To analyze the mechanisms of action and efficacy of these treatments against SARS-CoV-2 variants.
• * To emphasize the importance of continuous evaluation of therapeutic approaches.

Main Methods:

• * Literature review of current clinical and pharmaceutical research on COVID-19 treatments.
• * Classification of treatments based on molecular targets and mechanisms of action.
• * Analysis of treatment efficacy against emerging SARS-CoV-2 variants of concern.

Main Results:

• * Antiviral agents target various stages of the SARS-CoV-2 infection cycle.
• * Immune-based treatments focus on modulating the host inflammatory response.
• * Efficacy varies among treatments, particularly against different variants of concern.

Conclusions:

• * Current COVID-19 treatments offer diverse mechanisms to combat the virus and its effects.
• * Ongoing research and evaluation are essential to adapt strategies against evolving SARS-CoV-2 variants.
• * Therapeutic interventions remain critical, especially for populations not fully protected by vaccination.